title: Oncolytic viruses get a boost with first FDA-approval recommendation.
authors.forename: Elie
authors.initials: E
authors.lastname: Dolgin
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000276:immunology / Q000627:therapeutic use; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004345:Drug Industry / Q000331:legislation & jurisprudence; D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000276:immunology / Q000628:therapy; D050504:Oncolytic Viruses / Q000235:genetics* / Q000276:immunology*; D014481:United States; D014765:Viral Vaccines / Q000276:immunology / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D014765:Viral Vaccines; C464532:dl1520